Literature DB >> 2386094

The accumulation of 11C-methionine in cerebral glioma patients studied with PET.

M Kameyama1, R Shirane, J Itoh, K Sato, R Katakura, T Yoshimoto, J Hatazawa, M Itoh, T Ido.   

Abstract

Fourteen patients with cerebral gliomas were studied with positron emission tomography (PET) using L-[methyl-11C]methionine (11C-MET). Positive images of tumour were obtained in all cases regardless of histological grades. The analysis of differential absorption ratio (DAR) showed the higher accumulation of 11C-MET in high grade gliomas than in low grade gliomas. PET study with 11C-MET will be of great value not only in delineating the location of gliomas, but also in making a qualitative diagnosis from the view point of the biological properties of gliomas.

Entities:  

Mesh：

Substances：

Year:  1990        PMID： 2386094     DOI： 10.1007/bf01842885

Source DB:  PubMed          Journal:  Acta Neurochir (Wien)        ISSN： 0001-6268            Impact factor:   2.216


  23 in total

1.  STUDIES WITH RADIOACTIVE DI-AZO DYES. III. THE DISTRIBUTON OF RADIOACTIVE DYES IN TUMOR-BEARING MICE.

Authors:  F D Moore; L H Tobin; J C Aub
Journal:  J Clin Invest       Date:  1943-03       Impact factor: 14.808

2.  Positron emission tomography with 11C-methionine and computed tomography of intracranial tumours compared with histopathologic examination of multiple biopsies.

Authors:  M Mosskin; H von Holst; M Bergström; V P Collins; L Eriksson; P Johnström; G Norén
Journal:  Acta Radiol       Date:  1987 Nov-Dec       Impact factor: 1.990

3.  PET-FDG of untreated and treated cerebral gliomas.

Authors:  G Di Chiro; R A Brooks
Journal:  J Nucl Med       Date:  1988-03       Impact factor: 10.057

4.  Performance characteristics of a whole-body positron tomograph.

Authors:  T J Spinks; R Guzzardi; C R Bellina
Journal:  J Nucl Med       Date:  1988-11       Impact factor: 10.057

5.  Prognostic implications of the proliferative potential of low-grade astrocytomas.

Authors:  T Hoshino; L A Rodriguez; K G Cho; K S Lee; C B Wilson; M S Edwards; V A Levin; R L Davis
Journal:  J Neurosurg       Date:  1988-12       Impact factor: 5.115

6.  Blood flow and oxygen utilisation in the contralateral cerebral cortex of patients with untreated intracranial tumours as studied by positron emission tomography, with observations on the effect of decompressive surgery.

Authors:  R P Beaney; D J Brooks; K L Leenders; D G Thomas; T Jones; K E Halnan
Journal:  J Neurol Neurosurg Psychiatry       Date:  1985-04       Impact factor: 10.154

7.  Measurement of regional cerebral blood flow and oxygen utilisation in patients with cerebral tumours using 15O and positron emission tomography: analytical techniques and preliminary results.

Authors:  M Ito; A A Lammertsma; R J Wise; S Bernardi; R S Frackowiak; J D Heather; C G McKenzie; D G Thomas; T Jones
Journal:  Neuroradiology       Date:  1982       Impact factor: 2.804

8.  ECAT: a new computerized tomographic imaging system for positron-emitting radiopharmaceuticals.

Authors:  M E Phelps; E J Hoffman; S C Huang; D E Kuhl
Journal:  J Nucl Med       Date:  1978-06       Impact factor: 10.057

9.  Metabolic and hemodynamic evaluation of gliomas using positron emission tomography.

Authors:  J L Tyler; M Diksic; J G Villemure; A C Evans; E Meyer; Y L Yamamoto; W Feindel
Journal:  J Nucl Med       Date:  1987-07       Impact factor: 10.057
View more
  12 in total

1.  Dynamic study of methionine uptake in glioma using positron emission tomography.

Authors:  K Sato; M Kameyama; K Ishiwata; J Hatazawa; R Katakura; T Yoshimoto
Journal:  Eur J Nucl Med       Date:  1992

Review 2.  Discrimination between primary low-grade and high-grade glioma with 11C-methionine PET: a bivariate diagnostic test accuracy meta-analysis.

Authors:  Anna Falk Delgado; Alberto Falk Delgado
Journal:  Br J Radiol       Date:  2018-01-22       Impact factor: 3.039

Review 3.  Prediction of brain tumor therapy response by PET.

Authors:  R G Blasberg
Journal:  J Neurooncol       Date:  1994       Impact factor: 4.130

Review 4.  Value of 11C-methionine PET in imaging brain tumours and metastases.

Authors:  Andor W J M Glaudemans; Roelien H Enting; Mart A A M Heesters; Rudi A J O Dierckx; Ronald W J van Rheenen; Annemiek M E Walenkamp; Riemer H J A Slart
Journal:  Eur J Nucl Med Mol Imaging       Date:  2012-12-12       Impact factor: 9.236

Review 5.  The Potential of Metabolic Imaging.

Authors:  Valentina Di Gialleonardo; David M Wilson; Kayvan R Keshari
Journal:  Semin Nucl Med       Date:  2016-01       Impact factor: 4.446

Review 6.  11C-L-methionine positron emission tomography in the clinical management of cerebral gliomas.

Authors:  Tarun Singhal; Tanjore K Narayanan; Viney Jain; Jogeshwar Mukherjee; Joseph Mantil
Journal:  Mol Imaging Biol       Date:  2007-10-24       Impact factor: 3.488

7.  Proliferation-dependent changes in amino acid transport and glucose metabolism in glioma cell lines.

Authors:  Toshio Sasajima; Tadashi Miyagawa; Takamitsu Oku; Juri G Gelovani; Ronald Finn; Ronald Blasberg
Journal:  Eur J Nucl Med Mol Imaging       Date:  2004-05-13       Impact factor: 9.236

8.  Metabolic changes of glioma following chemotherapy: an experimental study using four PET tracers.

Authors:  K Sato; M Kameyama; K Ishiwata; R Katakura; T Yoshimoto
Journal:  J Neurooncol       Date:  1992-09       Impact factor: 4.130

9.  Clinical application of 18F-FUdR in glioma patients--PET study of nucleic acid metabolism.

Authors:  M Kameyama; K Ishiwata; Y Tsurumi; J Itoh; K Sato; R Katakura; T Yoshimoto; J Hatazawa; M Ito; T Ido
Journal:  J Neurooncol       Date:  1995       Impact factor: 4.130

10.  A comparison study of (11)C-methionine and (18)F-fluorodeoxyglucose positron emission tomography-computed tomography scans in evaluation of patients with recurrent brain tumors.

Authors:  Rajnish Sharma; Maria D'Souza; Abhinav Jaimini; Puja Panwar Hazari; Sanjeev Saw; Santosh Pandey; Dinesh Singh; Yachna Solanki; Nitin Kumar; Anil K Mishra; Anupam Mondal
Journal:  Indian J Nucl Med       Date:  2016 Apr-Jun
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.